(Q40077063)

English

Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.

scientific article published on 10 July 2007

Statements

Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit